Valsartan Impurity 33 | CAS 1071286-94-6 - Request Quote
Valsartan Impurity 33
| SZ CAT No: | SZ-V001076 |
| CAS No | 1071286-94-6 |
| Mol.F. | C19H20N2O2 |
| Mol.Wt. | 308.4 |
| Inv. Status | In Stock |
| Rel. CAS No | 1070968-85-2 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Valsartan Impurity 33 is chemically ((2'-Cyano-[1,1'-biphenyl]-4-yl)methyl)-L-valine. Valsartan Impurity 33 is supplied with detailed characterization data compliant with regulatory guideline. Valsartan Impurity 33 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Valsartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1071286-94-6
Purchase 1071286-94-6
Order 1071286-94-6
Enquire 1071286-94-6
price of 1071286-94-6
1071286-94-6 Supplier
1071286-94-6 Manufacturer
1071286-94-6 Exporter
buy high quality Valsartan Impurity 33
Purchase Valsartan Impurity 33
Valsartan Impurity 33 suppliers
Valsartan Impurity 33 manufacturers
Valsartan Impurity 33 price
Order Valsartan Impurity 33
Enquire Valsartan Impurity 33
Valsartan Impurity 33 cost
Valsartan Impurity 33 Supplier
Valsartan Impurity 33 Distributor
Valsartan Impurity 33 for Method Validation
Valsartan Reference Standard
Valsartan Impurity 33 for ANDA Filing
Valsartan Impurity 33 for Forced Degradation Studies
Valsartan Impurity 33 Identification Standards
Valsartan Impurity 33 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.